LAZCLUZE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 57894-080
  • Application number NDA219008
  • SPL ID da4a9239-16d7-46cf-b089-e943e0080015
  • SPL set ID c417f9ee-2027-4ed5-92ad-3c19266de16c
  • UNII 4A2Y23XK11
  • RxCUI 2691156
  • RxCUI 2691162
  • RxCUI 2691164
  • RxCUI 2691166

What the source publishes

Labeler
Janssen Biotech, Inc.
Active ingredients
lazertinib
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:57894-080_da4a9239-16d7-46cf-b089-e943e0080015
{
  "name": "LAZCLUZE",
  "splId": "da4a9239-16d7-46cf-b089-e943e0080015",
  "labels": [
    {
      "setId": "c417f9ee-2027-4ed5-92ad-3c19266de16c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c417f9ee-2027-4ed5-92ad-3c19266de16c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c417f9ee-2027-4ed5-92ad-3c19266de16c"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Janssen Biotech, Inc.",
  "finished": true,
  "packaging": [],
  "productId": "57894-080_da4a9239-16d7-46cf-b089-e943e0080015",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "57894-080",
  "deaSchedule": null,
  "genericName": "lazertinib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LAZERTINIB",
      "strength": "80 mg/1"
    }
  ],
  "applicationNumber": "NDA219008",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240820",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175605",
      "N0000175082",
      "N0000182141",
      "N0000190113"
    ],
    "unii": [
      "4A2Y23XK11"
    ],
    "rxcui": [
      "2691156",
      "2691162",
      "2691164",
      "2691166"
    ],
    "spl_set_id": [
      "c417f9ee-2027-4ed5-92ad-3c19266de16c"
    ],
    "pharm_class_epc": [
      "Kinase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Kinase Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]",
      "Breast Cancer Resistance Protein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Janssen Biotech, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:57894-080_da4a9239-16d7-46cf-b089-e943e0080015"